Item Type | Name |
Concept
|
Melanoma
|
Academic Article
|
Locoregional management of hepatic metastasis from primary uveal melanoma.
|
Academic Article
|
Surgically unresectable regional melanoma metastases in a patient with renal failure and peripheral vascular disease: are there safe and potentially effective treatments?
|
Academic Article
|
Conjunctival melanoma: bladder and upper urinary tract metastases.
|
Academic Article
|
Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience.
|
Academic Article
|
Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine.
|
Academic Article
|
Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.
|
Academic Article
|
Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma.
|
Academic Article
|
Locoregional immuno(bio)therapy for liver metastases.
|
Academic Article
|
Effect of the dose and composition of an autologous hapten-modified melanoma vaccine on the development of delayed-type hypersensitivity responses.
|
Academic Article
|
TCR rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine.
|
Academic Article
|
Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine.
|
Academic Article
|
Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study.
|
Academic Article
|
A pilot study of low-dose thalidomide and interferon alpha-2b in patients with metastatic melanoma who failed prior treatment.
|
Academic Article
|
Role of cytogenetics in management of uveal melanoma.
|
Academic Article
|
The biology and management of uveal melanoma.
|
Academic Article
|
Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor.
|
Academic Article
|
Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential.
|
Academic Article
|
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.
|
Academic Article
|
High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma.
|
Academic Article
|
The potential role of sunitinib targeting melanomas.
|
Academic Article
|
Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth.
|
Academic Article
|
Transhepatic therapies for metastatic uveal melanoma.
|
Academic Article
|
Tumor Necrosis Factor-a Blockade and Development of Uveal Melanoma: Expected Adverse Effect or Just Coincidence?
|
Academic Article
|
Double-Blinded, Randomized Phase II Study Using Embolization with or without Granulocyte-Macrophage Colony-Stimulating Factor in Uveal Melanoma with Hepatic Metastases.
|
Academic Article
|
Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.
|
Academic Article
|
Successes and setbacks of early investigational drugs for melanoma.
|
Academic Article
|
Uveal Melanoma Metastatic to the Liver: Chemoembolization With 1,3-Bis-(2-Chloroethyl)-1-Nitrosourea.
|
Academic Article
|
Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.
|
Academic Article
|
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells.
|
Academic Article
|
Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.
|
Academic Article
|
Autologous melanoma cell vaccine using monocyte-derived dendritic cells (NBS20/eltrapuldencel-T).
|
Academic Article
|
Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?
|
Academic Article
|
Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.
|
Academic Article
|
Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma.
|
Academic Article
|
Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
|
Academic Article
|
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
|
Academic Article
|
PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma.
|
Academic Article
|
Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
|
Academic Article
|
Effects of Oncogenic Gaq and Ga11 Inhibition by FR900359 in Uveal Melanoma.
|
Academic Article
|
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma.
|
Academic Article
|
IsomiRs and tRNA-derived fragments are associated with metastasis and patient survival in uveal melanoma.
|
Academic Article
|
A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
|
Academic Article
|
Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice.
|
Academic Article
|
An Outcome Assessment of a Single Institution's Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis.
|
Academic Article
|
Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma.
|
Academic Article
|
Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma.
|
Academic Article
|
Unique geospatial accumulations of uveal melanoma.
|
Academic Article
|
BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
|
Academic Article
|
Rapid, Fatal Acute Right Ventricular Failure After Locoregional Cytokine Therapy for Uveal Melanoma Liver Metastases.
|
Academic Article
|
Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma.
|
Academic Article
|
Orthotopic Human Metastatic Uveal Melanoma Xenograft Mouse Models: Applications for Understanding the Pathophysiology and Therapeutic Management of Metastatic Uveal Melanoma.
|
Academic Article
|
Correction to: BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
|
Academic Article
|
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma.
|
Academic Article
|
Review of bi-specific therapies in uveal melanoma.
|
Academic Article
|
Genetic Landscape and Emerging Therapies in Uveal Melanoma.
|
Academic Article
|
The Role of HGF/MET Signaling in Metastatic Uveal Melanoma.
|